Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ML.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ML.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ML.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ML.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MM.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MM.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used